Scarica l'app Stockscreener
8.07
2.67%
0.21
Dopo l'orario di chiusura:
8.07
Precedente Chiudi:
$7.86
Aprire:
$7.87
Volume 24 ore:
47,116
Relative Volume:
0.47
Capitalizzazione di mercato:
$139.28M
Reddito:
-
Utile/perdita netta:
$-33.82M
Rapporto P/E:
-0.3154
EPS:
-25.5891
Flusso di cassa netto:
$-66.04M
1 W Prestazione:
+2.02%
1M Prestazione:
+0.88%
6M Prestazione:
+2.02%
1 anno Prestazione:
+39.14%
Intervallo 1D:
$7.83
$8.10
Intervallo di 1 settimana:
$7.77
$8.305
Portata 52W:
$4.60
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Nome
Elicio Therapeutics Inc
Settore
Industria
Telefono
(857) 209-0050
Indirizzo
451 D STREET, 5TH FLOOR, BOSTON
Confronta ELTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
8.07 | 135.65M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie
Understanding the Setup: (ELTX) and Scalable Risk - Stock Traders Daily
How (ELTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What is the fair value of Elicio Therapeutics Inc. stock nowJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
Dividend Watch: Can Elicio Therapeutics Inc. stock hit record highs again2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
Aug Decliners: Why Elicio Therapeutics Inc stock could rally in 2025July 2025 Setups & Verified Chart Pattern Signals - moha.gov.vn
How Elicio Therapeutics Inc. stock reacts to Fed rate cutsCPI Data & Fast Entry High Yield Stock Tips - ulpravda.ru
Will Elicio Therapeutics Inc. stock benefit from green energy trendsWeekly Investment Summary & Reliable Entry Point Alerts - Улправда
Is Elicio Therapeutics Inc. stock ready for breakoutJuly 2025 Gainers & Entry Point Confirmation Alerts - Bölüm Sonu Canavarı
How rising interest rates impact Elicio Therapeutics Inc. stockJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - Улправда
FOMO Trade: Can Elicio Therapeutics Inc. stock hit record highs again2025 Geopolitical Influence & Entry and Exit Point Strategies - Улправда
How supply chain issues affect Elicio Therapeutics Inc. stockMarket Movers & Reliable Breakout Forecasts - DonanımHaber
Why Elicio Therapeutics Inc. stock could rally in 2025Earnings Risk Summary & Weekly High Potential Alerts - Улправда
Can Elicio Therapeutics Inc. stock withstand economic slowdownLong Setup & AI Forecasted Entry and Exit Points - Улправда
Elicio Therapeutics Earnings Notes - Trefis
Elicio Therapeutics reports inducement grants - TipRanks
Elicio Therapeutics Reports Inducement Grants - The Manila Times
Elicio Therapeutics (Nasdaq: ELTX) issues 157K options at $8.52 - Stock Titan
Understanding Momentum Shifts in (ELTX) - Stock Traders Daily
Elicio Therapeutics (ELTX) upgraded to buy: Here's why - MSN
Elicio’s cancer vaccine triggers broad anti-tumor immunity - Rare Cancer News
Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Regeneron (REGN) and Elicio Therapeutics (ELTX) - The Globe and Mail
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why - sharewise.com
Elicio reports antigen spreading in 87% of evaluated cancer patients - Investing.com
Elicio reports antigen spreading in 87% of evaluated cancer patients By Investing.com - Investing.com Australia
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial - Yahoo Finance
Pancreatic Ductal Adenocarcinoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Elicio Therapeutics, Cend Therapeutics, Silenseed, Amplia - Barchart.com
How Elicio Therapeutics Inc. (9HA) stock reacts to stronger dollarQuarterly Market Summary & Safe Capital Allocation Plans - Newser
How Elicio Therapeutics Inc. (9HA) stock reacts to new regulations2025 Winners & Losers & Long-Term Growth Plans - Newser
Will Elicio Therapeutics Inc. (9HA) stock benefit from mergersTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Avoiding Lag: Real-Time Signals in (ELTX) Movement - Stock Traders Daily
Can Elicio Therapeutics Inc. stock deliver surprise earnings beat2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
Can Elicio Therapeutics Inc. (9HA) stock sustain margin levelsAnalyst Downgrade & Safe Capital Growth Plans - Newser
Will Elicio Therapeutics Inc. stock benefit from AI adoptionWeekly Stock Recap & Weekly Stock Performance Updates - Newser
How Elicio Therapeutics Inc. (9HA) stock trades in high volatilityWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Is Elicio Therapeutics Inc. (9HA) stock undervalued historicallyTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Will Elicio Therapeutics Inc. (9HA) stock split increase liquidity2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
How Elicio Therapeutics Inc. (9HA) stock compares with top peers - Newser
Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025 - MSN
Discipline and Rules-Based Execution in ELTX Response - news.stocktradersdaily.com
Can Elicio Therapeutics Inc. (9HA) stock sustain breakout momentumQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Is Elicio Therapeutics Inc. stock a smart buy before Fed meeting2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Why Elicio Therapeutics Inc. (9HA) stock remains stableProfit Target & Consistent Return Investment Signals - newser.com
How Elicio Therapeutics Inc. stock performs in weak economyJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Can Elicio Therapeutics Inc. stock maintain operating marginsQuarterly Growth Report & Stock Timing and Entry Methods - newser.com
Retail investors are Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) biggest owners and were hit after market cap dropped US$8.5m - simplywall.st
Elicio Therapeutics Inc Azioni (ELTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):